Exploring the diversity of cancer-associated fibroblasts: insights into mechanisms of drug resistance
Frontiers in Cell and Developmental Biology · 16.05.2024 · 12
DOI: 10.3389/fcell.2024.1403122 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Cell and Developmental Biology, online erschienen am 16.05.2024. Verfasst von Anastasia N Kazakova und 8 weiteren Autor:innen. Beteiligte Einrichtung: Lopukhin Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, Moscow, Russia. Die Arbeit wurde bisher 41-mal zitiert (Crossref) und nennt 148 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Among the various stromal cell types within the tumor microenvironment, cancer-associated fibroblasts (CAFs) emerge as the predominant constituent, exhibiting a diverse array of oncogenic functions not intrinsic to normal fibroblasts. Their involvement spans across all stages of tumorigenesis, encompassing initiation, progression, and metastasis. Current understanding posits the coexistence of distinct subpopulations of CAFs within the tumor microenvironment across a spectrum of solid tumors, showcasing both pro- and antitumor activities. Recent advancements in single-cell transcriptomics have revolutionized our ability to meticulously dissect the heterogeneity inherent to CAF populations. Furthermore, accumulating evidence underscores the pivotal role of CAFs in conferring therapeutic resistance to tumors against various drug modalities. Consequently, efforts are underway to develop pharmacological agents specifically targeting CAFs.
Methods
This review embarks on a comprehensive analysis, consolidating data from 36 independent single-cell RNA sequencing investigations spanning 17 distinct human malignant tumor types.
Results
Our exploration centers on elucidating CAF population markers, discerning their prognostic relevance, delineating their functional contributions, and elucidating the underlying mechanisms orchestrating chemoresistance.
Discussion
Finally, we deliberate on the therapeutic potential of harnessing CAFs as promising targets for intervention strategies in clinical oncology.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Lopukhin Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, Moscow, Russia.
- Moscow Institute of Physics and Technology (National Research University), Dolgoprudny, Russia.
- Center for Precision Genome Editing and Genetic Technologies for Biomedicine, Lopukhin Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, Moscow, Russia.
- Institute of Experimental Oncology and Biomedical Technologies, Privolzhsky Research Medical University, Nizhny Novgorod, Russia.
- Institute for Regenerative Medicine, Sechenov University, Moscow, Russia.
- Faculty of Biology, Lomonosov Moscow State University, Moscow, Russia.
Zitieren
APA
Kazakova, A. N., Lukina, M. M., Anufrieva, K. S., Bekbaeva, I. V., Ivanova, O. M., Shnaider, P. V., Slonov, A., Arapidi, G. P., & Shender, V. O. (2024). Exploring the diversity of cancer-associated fibroblasts: insights into mechanisms of drug resistance. Frontiers in Cell and Developmental Biology, 12. https://doi.org/10.3389/fcell.2024.1403122
Vancouver
Kazakova AN, Lukina MM, Anufrieva KS, Bekbaeva IV, Ivanova OM, Shnaider PV, et al. Exploring the diversity of cancer-associated fibroblasts: insights into mechanisms of drug resistance. Frontiers in Cell and Developmental Biology. 2024;12. doi:10.3389/fcell.2024.1403122
BibTeX
@article{Kazakova2024,
author = {Kazakova, Anastasia N and Lukina, Maria M and Anufrieva, Ksenia S and Bekbaeva, Irina V and Ivanova, Olga M and Shnaider, Polina V and Slonov, Andrey and Arapidi, Georgij P and Shender, Victoria O},
title = {Exploring the diversity of cancer-associated fibroblasts: insights into mechanisms of drug resistance},
journal = {Frontiers in Cell and Developmental Biology},
year = {2024},
volume = {12},
doi = {10.3389/fcell.2024.1403122}
}
EUVIMED